Controlled Clinical Trials,volume 24,issue 6  (12-2003)

Period of time： 2003年6期

Publisher： Elsevier

Founded in： 1976

Total resources： 2

ISSN： 0197-2456

Subject： R4 Clinical Medicine

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Controlled Clinical Trials,volume 24,issue 6

Menu

Preface

By Neaton J.D. in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 667-668

Elsevier

Abstract Access to resources Recommend Favorite

Determining a maximum tolerated cumulative dose: dose reassignment within the TITE-CRM

By Braun T.M., Levine J.E., Ferrara J.L.M. in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 669-681

Elsevier

Abstract Access to resources Recommend Favorite

On the use and utility of the Weibull model in the analysis of survival data

By Carroll K.J. in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 682-701

Elsevier

Abstract Access to resources Recommend Favorite

Web-based decision support for clinical trial eligibility determination in an international clinical trials network

By Breitfeld P.P., Ullrich F., Anderson J., Crist W.M. in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 702-710

Elsevier

Abstract Access to resources Recommend Favorite

Use of a run-in period to decrease loss to follow-up in the contact lens and myopia progression (CLAMP) study

By Walline J.J., Jones L.A., Mutti D.O., Zadnik K. in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 711-718

Elsevier

Abstract Access to resources Recommend Favorite

Limiting loss to follow-up in a multicenter randomized trial in orthopedic surgery

By Sprague S., Leece P., Bhandari M., Tornetta P., Schemitsch E., Swiontkowski M.F., on behalf of the S.P.R.I.N.T. Investigators in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 719-725

Elsevier

Abstract Access to resources Recommend Favorite

Determination of vital status at the end of the DIG trial

By Collins J.F., Howell C.L., Horney R.A., for the Digitalis Investigation Group DIG Investigators in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 726-730

Elsevier

Abstract Access to resources Recommend Favorite

Use of a single global assessment to reduce missing data in a clinical trial with follow-up at one year

By Vickers A.J., McCarney R. in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 731-735

Elsevier

Abstract Access to resources Recommend Favorite

An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2x2x2x2x2x2 factorial design (IMPACT)

By Apfel C.C., Korttila K., Abdalla M., Biedler A., Kranke P., Pocock S.J., Roewer N. in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 736-751

Elsevier

Abstract Access to resources Recommend Favorite

The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics

By Bots M.L., Evans G.W., Riley W., Meijer R., McBride K.H., Paskett E.D., Helmond F.A., Grobbee D.E., for the OPAL Investigators in (2003)

Controlled Clinical Trials,volume 24,issue 6 , Vol. 24, Iss. 6, 2003-12 , pp. 752-775

Elsevier

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 12 item(s)